How to Run an MLR Review on a Pharma Marketing Video Step by Step
An MLR review for pharma marketing video requires airtight documentation, claim-level traceability, and a review process that satisfies Medical, Legal, and Regulatory in the right sequence.
Medical, Legal, and Regulatory (MLR) review is the most structured review process most video teams will ever encounter. It is not like a client approval round. Every claim in the video needs to be traceable to a source. Every reviewer's comments need to be documented. And the approval record is not just for project management: it is a compliance artifact.
Running an MLR review on a pharma marketing video requires a process that meets the discipline of that environment. Here is how to structure it step by step, and how to use a purpose-built video review tool to support the documentation requirements.
Understanding the MLR Review Audience
The three functions in an MLR review have different concerns.
Medical reviewers are checking scientific accuracy. Do the efficacy claims reflect what the data actually shows? Are adverse event statements present and accurate? Is the benefit-risk balance appropriately communicated?
Legal reviewers are checking for claims that could create regulatory or liability exposure. Are comparative statements substantiated? Are any off-label implications present? Is the promotional intent clear and appropriate?
Regulatory reviewers are checking for compliance with applicable promotional guidelines. In the US context, that typically means FDA promotional labeling regulations. In other markets, applicable local codes apply.
These three lenses are not interchangeable. Routing all three to a video at once without a sequenced structure creates confusion about whose feedback takes precedence.
It is a structured review where Medical establishes scientific accuracy, Legal reviews for claims exposure, and Regulatory confirms promotional compliance, ideally in sequence.
The Pre-Submission Package
Before the video enters formal MLR review, the content team needs to prepare a claims package. This is the document that MLR reviewers will use alongside the video to check each claim against its source reference.
For a pharma marketing video, the claims package includes:
- A script with each promotional claim numbered
- A reference document that maps each claim number to a supporting source (PI, clinical study, approved label language)
- Any visual claims shown in graphics or lower thirds, also mapped to references
This is not optional work. Without it, the Medical reviewer cannot do their job. With it, the review is faster because the reviewer is not hunting for where each claim came from.
Upload both the video file and the claims reference document to your review project in PlayPause so the reviewer can reference both in the same session.
Sequencing the Review
The sequenced model is slower in calendar time than a parallel review, but it produces fewer total conflicts and revision cycles. When Medical changes a claim for accuracy, that change may affect Legal's assessment. Running them simultaneously means Legal reviews a version that is about to change.
Some organizations run Medical and Legal in parallel for efficiency. If you do this, be explicit that the Medical-resolved version is what Legal formally approves, not the draft they initially reviewed.
Tracking Review Status Without Confusion
One of the hardest parts of MLR review for video content is tracking which reviewer has seen which version. This is especially true when a claim is revised and the video needs to go back to one function for re-review without requiring the others to re-review the entire piece.
In PlayPause, each version of the video is uploaded as a distinct version on the same project thread. When a Medical reviewer reviews v1 and flags claim 7 as needing revision, that comment is pinned to the exact frame where the claim appears. The editor revises claim 7 and uploads v2. Only claim 7 changed. The Medical reviewer can go to their original comment on v1, see the resolution on v2, and confirm the fix without re-watching the entire video.
This is material for MLR efficiency. Re-watching a five-minute promotional video in its entirety for a single claim correction is expensive for senior medical reviewers' time.
Reviewers download files, comment in separate documents, versions pile up in email threads, claim-level traceability is manual and error-prone
Comments are pinned to specific frames and timestamps, version history is automatic, each reviewer's comments are attributed and time-stamped, claim-level issues traceable directly to the video moment
Documentation Requirements
For pharma promotional content, the review record is a compliance document. It needs to show:
- Which version was reviewed by each function
- When the review happened
- What comments were raised and whether they were addressed
- Who provided final approval and when
PlayPause's project thread provides the first three elements automatically. Every comment is attributed to the reviewer's name, time-stamped, and linked to a specific version. For final approval documentation, the standard practice is to have each MLR approver leave an explicit approval comment on the final version, which is also time-stamped and attributed.
For formal MLR documentation that needs to be filed in a regulatory archive, export the comment thread from PlayPause and store it alongside the final approved video file. This gives you a complete record of who reviewed what and when.
- Claims package prepared before any review starts
- Each claim numbered and mapped to its source reference
- Version uploaded to PlayPause per review round, not emailed
- Each reviewer leaves comments attributed by name
- Resolved changes traceable from original comment to revised version
- Explicit approval comment from each MLR function on final version
What to Do With Conflicting MLR Feedback
MLR conflicts happen when Medical wants to strengthen a claim for scientific clarity and Legal wants to soften it for liability reasons. This is a real tension and it is not resolved by the video team.
Your job when this happens is to document both notes clearly, flag the conflict to the MLR chair or the medical-legal arbiter within your organization, and wait for a direction before making any change. Do not attempt to thread the needle between conflicting MLR notes yourself. Any compromise wording needs MLR sign-off.
In PlayPause, you can add a comment on the contested frame noting the conflict and the pending resolution request. This documents that you identified and escalated the issue rather than proceeding without direction.
For more on managing conflicting feedback from multiple senior reviewers, see our post on how to handle conflicting feedback on a corporate video from multiple executives.
Protecting the Video During Review
Pharma promotional content in review is highly sensitive. Share links should always be password-protected and set to expire after the review window closes. Disable downloads so reviewers cannot retain copies of unreleased promotional material.
These controls are table stakes for pharmaceutical content review, not optional security theatre. A leaked pre-approval promotional video creates real regulatory and reputational exposure.
In pharma, the review process is not documentation of your creative decision. It is a regulatory compliance record.
The MLR Review Record as a Product
Here is a framing I find useful: the MLR review record is itself a deliverable, not a byproduct. When the video is approved and published, the review record is what proves it was reviewed appropriately.
Treat it as such. At the end of every MLR review, make sure the documentation is complete: the claims package, the version history, the comment thread, and the final approval confirmation from each function. Archive it with the published video and the original source references.
For more on building a durable approval audit trail, see our post on audit trail for every note given on a feature film post production, which covers the documentation principles that apply across high-stakes review contexts.
For the broader question of what a medical affairs team needs in a review platform, see our post on what medical affairs teams need in a video review platform for promotional content.
Pricing
For pharma teams and medical affairs groups, the Enterprise plan at $27 per month is available for teams that need SSO, advanced access controls, and priority support. The Agency plan at $19 per month is the most popular for teams with ongoing promotional video production.
Guest reviewers, including external Medical, Legal, and Regulatory contacts, are free in PlayPause. You do not pay per MLR reviewer.
If your team is managing pharma promotional video review through email attachments and PDF comment documents, you are creating unnecessary compliance risk. Start PlayPause free and give your next MLR review the documentation structure it requires.
Sumana Kumar writes about video review and approval workflows for PlayPause. She covers how studios, agencies, and creators collect frame-accurate feedback, manage versions, and reach a clean sign-off with fewer rounds.
Related resources
Keep reading
Bring your team into one review space
Centralize feedback, lock approvals, and deliver faster, start free today.
Sign Up for Free